Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02287025
Title A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Out Comes?
Recruitment Terminated
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Bayer
Indications

colorectal cancer

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.